|
ZNF17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4432899320127E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63180580159406E-12 |
| Normal-vs-Stage2 |
2.42028619368284E-13 |
| Normal-vs-Stage3 |
1.62458935193399E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
7.866200E-01 |
| Stage1-vs-Stage3 |
4.994200E-02 |
| Stage1-vs-Stage4 |
4.006000E-04 |
| Stage2-vs-Stage3 |
1.238050E-01 |
| Stage2-vs-Stage4 |
5.258800E-03 |
| Stage3-vs-Stage4 |
1.499620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62536650805123E-12 |
| Normal-vs-AfricanAmerican |
5.37629940566831E-11 |
| Normal-vs-Asian |
7.05868696826428E-12 |
| Caucasian-vs-AfricanAmerican |
7.161000E-01 |
| Caucasian-vs-Asian |
8.968000E-02 |
| AfricanAmerican-vs-Asian |
4.574200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.22124532708767E-15 |
| Normal-vs-Female |
1.62592161956354E-12 |
| Male-vs-Female |
9.636200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.10782519111308E-15 |
| Normal-vs-Age(41-60Yrs) |
1.62569957495862E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
5.6904999999996E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.730600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.124200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.560800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.865000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.915400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.208100E-04 |
| Classical-VS-Follicular |
6.247400E-01 |
| Classical-VS-Other |
4.074000E-01 |
| Classical-VS-Normal |
1.67366120962242E-12 |
| Tall-VS-Follicular |
1.116090E-02 |
| Tall-VS-Other |
4.656400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.692200E-01 |
| Follicular-VS-Normal |
1.67066360745594E-12 |
| Other-VS-Normal |
3.14709999948981E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.1094237467878E-15 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.768300E-02 |
|
|
